Refluxing Anastomosis in Transplant Kidney Ureter
Vesicoureteral reflux (VUR) in kidney transplants is generally well-tolerated and requires intervention only when patients develop recurrent febrile urinary tract infections despite antimicrobial prophylaxis. 1
Clinical Significance and Risk Profile
VUR occurs in approximately 12% of kidney transplant recipients after non-refluxing ureteroneocystostomy 2. The primary concern is not the reflux itself, but rather its potential to cause recurrent pyelonephritis in the transplanted kidney, which can lead to:
- Repeated hospitalizations
- Increased morbidity
- Potential graft dysfunction
- Need for prolonged antimicrobial prophylaxis
Most patients with transplant kidney VUR remain asymptomatic and do not require surgical intervention 1. The reflux becomes clinically significant only when associated with recurrent febrile UTIs that persist despite appropriate antibiotic prophylaxis.
Management Algorithm
Conservative Management (First-Line)
- Antimicrobial prophylaxis is the initial approach for all patients with documented VUR
- Continue surveillance with periodic urine cultures
- Monitor for breakthrough infections
- Assess graft function regularly with ultrasound and serum creatinine
Indications for Surgical Intervention
Surgical treatment is reserved for patients who develop recurrent pyelonephritis despite antimicrobial prophylaxis 1.
Treatment Options by VUR Grade
Low-Grade VUR (Grades I-III)
- Endoscopic Deflux injection may be considered 1, though evidence in transplant patients is concerning
- A 2018 pediatric study showed 100% failure rate (11/11 patients) with Deflux in transplant kidneys 2
- Post-Deflux redo reimplantation carried a 50% complication rate including recurrent reflux and ureterovesical junction obstruction 2
High-Grade VUR (Grades IV-V)
- Open surgical reconstruction is the preferred approach 1
- Primary ureteral reimplantation showed no complications in one series, compared to 50% complications after failed Deflux 2
Critical Pitfalls to Avoid
Do not rush to surgical intervention for asymptomatic VUR. Nearly half of patients (49%) can be successfully managed with surveillance alone 3. The decision to intervene should be driven by clinical symptoms (recurrent febrile UTIs) rather than radiographic findings alone.
Avoid Deflux as first-line surgical treatment in transplant patients. Unlike native kidneys, the transplant setting has demonstrated poor results with endoscopic injection therapy 2. The tenuous vascularity of the transplant ureter and surrounding scar tissue make this approach particularly problematic, with subsequent open repair carrying higher complication rates.
Ensure experienced surgical team for any reconstruction. Revision of vesicoureteral anastomosis in transplant patients is technically challenging due to scar tissue and compromised ureteral blood supply 1. When performed by experienced teams, these procedures can salvage grafts without significantly impacting long-term graft survival 4.
Surgical Technique Considerations
If surgical reconstruction becomes necessary, the Lich-Gregoir extravesical technique demonstrates superior outcomes compared to Politano-Leadbetter or U-stitch techniques, with significantly lower rates of urinary leakage (RR 0.47) and hematuria (RR 0.28) 5. This applies whether or not ureteral stenting is used.